DE2425764A1 - Tabletten - Google Patents

Tabletten

Info

Publication number
DE2425764A1
DE2425764A1 DE19742425764 DE2425764A DE2425764A1 DE 2425764 A1 DE2425764 A1 DE 2425764A1 DE 19742425764 DE19742425764 DE 19742425764 DE 2425764 A DE2425764 A DE 2425764A DE 2425764 A1 DE2425764 A1 DE 2425764A1
Authority
DE
Germany
Prior art keywords
tablets
nicotinic acid
release
active ingredient
continuous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742425764
Other languages
German (de)
English (en)
Inventor
Surendra Sangekar
Prabhakar Ranchhordas Sheth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2425764A1 publication Critical patent/DE2425764A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19742425764 1973-05-29 1974-05-28 Tabletten Pending DE2425764A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36444373A 1973-05-29 1973-05-29

Publications (1)

Publication Number Publication Date
DE2425764A1 true DE2425764A1 (de) 1975-01-02

Family

ID=23434551

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742425764 Pending DE2425764A1 (de) 1973-05-29 1974-05-28 Tabletten

Country Status (4)

Country Link
JP (1) JPS5031022A (enExample)
DE (1) DE2425764A1 (enExample)
FR (1) FR2231365B1 (enExample)
GB (1) GB1422768A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3527852A1 (de) * 1984-08-03 1986-02-20 Nippon Shinyaku Co., Ltd., Kyoto Pharmazeutische zubereitung und verfahren zu ihrer herstellung
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS5974374U (ja) * 1982-11-11 1984-05-19 セイコーインスツルメンツ株式会社 携帯時計の文字板保持構造
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
ES2096103T3 (es) * 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
US10105358B2 (en) * 2013-05-09 2018-10-23 Zeenar Enterprises Pty Ltd Niacin formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617593A1 (de) * 1965-10-12 1971-04-29 Leo Pharm Prod Ltd Verfahren zur Herstellung von Tabletten oder Pillen

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3527852A1 (de) * 1984-08-03 1986-02-20 Nippon Shinyaku Co., Ltd., Kyoto Pharmazeutische zubereitung und verfahren zu ihrer herstellung
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems

Also Published As

Publication number Publication date
FR2231365B1 (enExample) 1977-11-04
JPS5031022A (enExample) 1975-03-27
FR2231365A1 (enExample) 1974-12-27
GB1422768A (en) 1976-01-28

Similar Documents

Publication Publication Date Title
DE3875705T2 (de) Carbidopa-levodopa-zusammensetzung mit gesteuerter freigabe.
DE2224534C3 (de) Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe
DE68902531T2 (de) Dispergierbare zubereitung.
DE1292783B (de) Verfahren zum Herstellen einer Tablette mit Depotwirkung
DE1467906A1 (de) Verfahren zur Herstellung von sich langsam loesenden Tabletten
DE2128461A1 (de) Pharmazeutisches Präparat
DE69108022T3 (de) Arzneimittel.
DE2721603A1 (de) Beschichtete koernchen aus alkalimetallsalzen der polyacrylsaeure und verfahren zu ihrer herstellung
DE2706660A1 (de) Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung
EP1509207A1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
EP0469328A1 (de) Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
DE2425764A1 (de) Tabletten
DE68905613T2 (de) Pharmazeutische Zubereitung.
DE1088192B (de) Verfahren zur Herstellung von tablettierbaren oder direkt verwendbaren Arzneimittelgranulaten mit einstellbaren Freigabeeigenschaften
DE68914683T2 (de) Arzneimittelzusammensetzung für die schnelle verabreichung des aktiven bestandteils, der aus einer festen dispersion und einem oberflächenaktiven mittel besteht.
EP0208144B1 (de) Ambroxol oder bromhexin enthaltendes arzneimittelgranulat
CH683824A5 (de) Zusammensetzung als Mittel zur Behandlung von Entzündungen.
DE69002186T2 (de) Kalziumpantothenatzusammensetzung.
DE1935879B2 (de) Verfahren zur Herstellung eines pharmazeutischen Lithium-Präparates
DE2439538B2 (de) Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe
DE2148391A1 (de) Arzneimittel mit verlängerter Wirk stoffabgabe
DE2448119A1 (de) Pharmazeutische zubereitungen
DE1925919C3 (de) Tablette für die gleichmäßige Freisetzung eines Arzneimittels
DE1219176B (de) Verfahren zur Herstellung von Arzneipraeparaten mit verzoegerter Wirkstoffabgabe
DE1492123A1 (de) Verfahren zur Herstellung von Arzneipraeparaten in Tablettenform

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee